Low bone mineral density due to secondary hyperparathyroidism in the
24‐hydroxylase
bone histomorphometry
osteomalacia
parathyroid hormone
renal phosphate wasting
Journal
FASEB bioAdvances
ISSN: 2573-9832
Titre abrégé: FASEB Bioadv
Pays: United States
ID NLM: 101733210
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
23
09
2019
revised:
23
09
2019
accepted:
27
04
2020
entrez:
4
7
2020
pubmed:
4
7
2020
medline:
4
7
2020
Statut:
epublish
Résumé
Low bone mineral density (BMD)-diagnosed as osteoporosis or osteopenia-has been reported as a new characteristic feature of Fabry disease; however, the mechanism underlying the development of low BMD is unknown. We previously revealed that a mouse model of Fabry disease [
Identifiants
pubmed: 32617522
doi: 10.1096/fba.2019-00080
pii: FBA21129
pmc: PMC7325589
doi:
Types de publication
Journal Article
Langues
eng
Pagination
365-381Informations de copyright
© 2020 The Authors.
Références
Curr Opin Nephrol Hypertens. 2011 Jul;20(4):337-44
pubmed: 21610497
Am J Physiol Renal Physiol. 2015 Aug 1;309(3):F189-203
pubmed: 26084932
Q J Med. 1983 Summer;52(207):332-48
pubmed: 6647748
Bone Rep. 2018 Mar 17;8:125-134
pubmed: 29955631
Pediatr Nephrol. 2010 Apr;25(4):603-8
pubmed: 20012997
J Bone Miner Res. 1987 Dec;2(6):595-610
pubmed: 3455637
Kidney Int. 2010 Sep;78(5):463-72
pubmed: 20531451
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1405-15
pubmed: 20219826
J Biol Chem. 1999 Feb 26;274(9):5620-5
pubmed: 10026179
J Bone Miner Res. 2004 Mar;19(3):429-35
pubmed: 15040831
Biochem J. 2013 Dec 15;456(3):373-83
pubmed: 24094090
Scand J Rheumatol. 2010 Mar;39(2):171-4
pubmed: 20001766
Kidney Int. 1996 Apr;49(4):981-5
pubmed: 8691748
Genet Med. 2007 Dec;9(12):812-8
pubmed: 18091430
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1974-86
pubmed: 25318757
Stain Technol. 1958 Nov;33(6):273-7
pubmed: 13603078
Endocrinology. 2017 Oct 1;158(10):3629-3646
pubmed: 28938491
Kidney Int. 2006 Sep;70(5):882-91
pubmed: 16820793
Clin Biochem. 2012 Aug;45(12):928-35
pubmed: 22504058
J Steroid Biochem Mol Biol. 2019 Apr;188:141-146
pubmed: 30654108
J Biol Chem. 1992 Jul 5;267(19):13757-62
pubmed: 1618870
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2540-4
pubmed: 9122231
N Engl J Med. 1967 May 25;276(21):1163-7
pubmed: 6023233
Clin Biochem. 2012 Aug;45(12):920-7
pubmed: 22480789
Am J Physiol. 1994 Mar;266(3 Pt 2):F477-85
pubmed: 8160797
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):376-82
pubmed: 20362668
Best Pract Res Clin Rheumatol. 2008 Dec;22(6):1127-39
pubmed: 19041081
Rev Endocr Metab Disord. 2010 Dec;11(4):237-51
pubmed: 21234807
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:22-7
pubmed: 24388948
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6423-7
pubmed: 10339603
J Am Soc Nephrol. 2004 Apr;15(4):892-900
pubmed: 15034091
Curr Osteoporos Rep. 2007 Dec;5(4):146-52
pubmed: 18430388
Clin Genet. 2005 Jul;68(1):93-5
pubmed: 15952993
Kidney Int. 2011 Jun;79(12):1370-8
pubmed: 21389978
J Bone Miner Metab. 2015 Sep;33(5):467-73
pubmed: 26197863
JIMD Rep. 2014;17:29-36
pubmed: 25062758
J Nutr Biochem. 2014 Jan;25(1):58-65
pubmed: 24314866
J Am Soc Nephrol. 1999 Dec;10(12):2465-73
pubmed: 10589683
Virchows Arch. 2011 Apr;458(4):477-86
pubmed: 21328014
Kidney Int. 2008 Nov;74(10):1343-53
pubmed: 18784644
Virchows Arch. 2000 Jan;436(1):36-42
pubmed: 10664160
Curr Osteoporos Rep. 2008 Dec;6(4):130-3
pubmed: 19032922
FASEB J. 2018 Aug;32(8):4544-4559
pubmed: 29553830
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5372-7
pubmed: 9560283